---

Miguel Forte

Chief Executive Officer, Zelluna Immunotherapy and Chief Commercialization Officer and Chair of Commercialization Committee, International Society of Cellular Therapy

“The big change our industry needs (and it’s starting to happen) is the establishment and validation of a new overall business value model – a model that rests on new approaches to product development, and that is particularly attentive to patient needs, expectations and contributions; a model that brings faster and more comprehensive market access approaches, including regulatory approval, new payer and reimbursement models and customer education.”

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018